Is Rosetta Genomics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Rosetta Genomics Ltd (ROSGQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Rosetta Genomics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Rosetta Genomics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Rosetta Genomics Ltd?

Muslim investors may consider investing in Rosetta Genomics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Rosetta Genomics Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Rosetta Genomics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Rosetta Genomics Ltd updated?

The Shariah compliance status of Rosetta Genomics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Rosetta Genomics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Rosetta Genomics Ltd?

You can check the latest Shariah compliance status of Rosetta Genomics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Analyst's Ratings for Rosetta Genomics Ltd (ROSGQ)

Based on 9 analysts giving stock ratings to Rosetta Genomics Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Rosetta Genomics Ltd. Stock Analysis ROSGQ

United States Health Care Nano Cap

Rosetta Genomics Ltd. engages in the provision of therapeutic, diagnostic product development, and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY, and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing a diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.

Financial Metrics & Statements of Rosetta Genomics Ltd (ROSGQ)

FAQ's for Rosetta Genomics Ltd (ROSGQ)

According to Musaffa’s Shariah screening methodology, Rosetta Genomics Ltd (ROSGQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.